AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in AJCN
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morley, J. E
Right arrow Articles by Wilson, M.-M. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morley, J. E
Right arrow Articles by Wilson, M.-M. G
Agricola
Right arrow Articles by Morley, J. E
Right arrow Articles by Wilson, M.-M. G
American Journal of Clinical Nutrition, Vol. 83, No. 4, 735-743, April 2006
© 2006 American Society for Nutrition


REVIEW ARTICLE

Cachexia: pathophysiology and clinical relevance1,2

John E Morley, David R Thomas and Margaret-Mary G Wilson

1 From the Division of Geriatric Medicine, Saint Louis University School of Medicine, St Louis, MO (JEM, DRT, and M-MGW), and GRECC, VA Medical Center, Saint Louis, MO (JEM)

Cachexia causes weight loss and increased mortality. It affects more than 5 million persons in the United States. Other causes of weight loss include anorexia, sarcopenia, and dehydration. The pathophysiology of cachexia is reviewed in this article. The major cause appears to be cytokine excess. Other potential mediators include testosterone and insulin-like growth factor I deficiency, excess myostatin, and excess glucocorticoids. Numerous diseases can result in cachexia, each by a slightly different mechanism. Both nutritional support and orexigenic agents play a role in the management of cachexia.

Key Words: Cachexia • pathogenesis • sarcopenia • weight loss


Related articles in AJCN:

Continuing Medical Education

AJCN 2006 83: 923-924. [Full Text]  



This article has been cited by other articles:


Home page
DiabetesHome page
D. S. Hittel, J. R. Berggren, J. Shearer, K. Boyle, and J. A. Houmard
Increased Secretion and Expression of Myostatin in Skeletal Muscle From Extremely Obese Women
Diabetes, January 1, 2009; 58(1): 30 - 38.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Laviano, A. Inui, D. L. Marks, M. M. Meguid, C. Pichard, F. Rossi Fanelli, and M. Seelaender
Neural control of the anorexia-cachexia syndrome
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1000 - E1008.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
G. D. Summers, C. M. Deighton, M. J. Rennie, and A. H. Booth
Rheumatoid cachexia: a clinical perspective
Rheumatology, August 1, 2008; 47(8): 1124 - 1131.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
E. Cereda, C. Pusani, D. Limonta, and A. Vanotti
The Association of Geriatric Nutritional Risk Index and Total Lymphocyte Count with Short-Term Nutrition-Related Complications in Institutionalised Elderly
J. Am. Coll. Nutr., June 1, 2008; 27(3): 406 - 413.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
Md. I. Hassan, A. Waheed, S. Yadav, T. P. Singh, and F. Ahmad
Zinc {alpha}2-Glycoprotein: A Multidisciplinary Protein
Mol. Cancer Res., June 1, 2008; 6(6): 892 - 906.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
D. D. Bannerman, A. C. W. Kauf, M. J. Paape, H. R. Springer, and J. P. Goff
Comparison of Holstein and Jersey Innate Immune Responses to Escherichia coli Intramammary Infection
J Dairy Sci, June 1, 2008; 91(6): 2225 - 2235.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Depke, G. Fusch, G. Domanska, R. Geffers, U. Volker, C. Schuett, and C. Kiank
Hypermetabolic Syndrome as a Consequence of Repeated Psychological Stress in Mice
Endocrinology, June 1, 2008; 149(6): 2714 - 2723.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. D. Wagner
Possible mechanisms underlying the development of cachexia in COPD
Eur. Respir. J., March 1, 2008; 31(3): 492 - 501.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Complex chronic comorbidities of COPD
Eur. Respir. J., January 1, 2008; 31(1): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. V. N. Bacurau, M. A. Belmonte, F. Navarro, M. R. Moraes, F. L. Pontes Jr., J. L. Pesquero, R. C. Araujo, and R. F. P. Bacurau
Effect of a High-Intensity Exercise Training on the Metabolism and Function of Macrophages and Lymphocytes of Walker 256 Tumor Bearing Rats
Experimental Biology and Medicine, November 1, 2007; 232(10): 1289 - 1299.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Chen, D. Sun, V. M. R. Krishnamurthy, and R. Rabkin
Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1856 - E1862.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Acharyya and D. C. Guttridge
Cancer Cachexia Signaling Pathways Continue to Emerge Yet Much Still Points to the Proteasome
Clin. Cancer Res., March 1, 2007; 13(5): 1356 - 1361.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. M Marcora, K. R Chester, G. Mittal, A. B Lemmey, and P. J Maddison
Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis
Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1463 - 1472.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The American Society for Nutrition